BR9916746A - Antiinflammatory compounds that inhibit cell adhesion - Google Patents

Antiinflammatory compounds that inhibit cell adhesion

Info

Publication number
BR9916746A
BR9916746A BR9916746-8A BR9916746A BR9916746A BR 9916746 A BR9916746 A BR 9916746A BR 9916746 A BR9916746 A BR 9916746A BR 9916746 A BR9916746 A BR 9916746A
Authority
BR
Brazil
Prior art keywords
cell adhesion
inhibit cell
compounds
antiinflammatory compounds
formula
Prior art date
Application number
BR9916746-8A
Other languages
Portuguese (pt)
Inventor
David L Arendsen
Pramila Bhatia
Steven A Boyd
Kevin R Condroski
Jennifer C Freeman
Indrani W Gunawardana
Kraig Lartey
Catherine M Mccarty
Nicholas A Mort
Meena V Patel
Michael A Staeger
Andrew O Stewart
David M Stout
Gui-Dong Zhu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/325,336 external-priority patent/US6232320B1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from PCT/US1999/014596 external-priority patent/WO2000075145A1/en
Publication of BR9916746A publication Critical patent/BR9916746A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"COMPOSTOS ANTIINFLAMATóRIOS QUE INIBEM ADESãO DE CéLULA". Os compostos possuindo a fórmula (I) são úteis para o tratamento de inflamação. Também são reveladas composições farmacêuticas compreendendo os compostos da fórmula (I) e processos para inibir/tratar doenças inflamatórias em um mamífero."ANTI-INFLAMMATORY COMPOUNDS THAT INHIBIT CELL ADHESION". The compounds having formula (I) are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising the compounds of formula (I) and processes for inhibiting / treating inflammatory diseases in a mammal.

BR9916746-8A 1999-06-03 1999-06-28 Antiinflammatory compounds that inhibit cell adhesion BR9916746A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/325,336 US6232320B1 (en) 1998-06-04 1999-06-03 Cell adhesion-inhibiting antiinflammatory compounds
PCT/US1999/014596 WO2000075145A1 (en) 1999-06-03 1999-06-28 Cell adhesion-inhibiting antiinflammatory compounds

Publications (1)

Publication Number Publication Date
BR9916746A true BR9916746A (en) 2005-01-11

Family

ID=56289920

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916746-8A BR9916746A (en) 1999-06-03 1999-06-28 Antiinflammatory compounds that inhibit cell adhesion

Country Status (3)

Country Link
JP (1) JP2004509059A (en)
BR (1) BR9916746A (en)
CA (1) CA2390948A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745050A1 (en) * 2004-05-04 2007-01-24 F.Hoffmann-La Roche Ag Thienopyridines as ikk inhibitors
AU2005238178A1 (en) * 2004-05-04 2005-11-10 F. Hoffmann-La Roche Ag Thienopyridazines as IKK inhibitors
JP2008501758A (en) 2004-06-09 2008-01-24 グラクソ　グループ　リミテッド Pyrrolopyridine derivatives
EP1773826A4 (en) * 2004-07-02 2009-06-03 Exelixis Inc C-met modulators and method of use
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1802632B1 (en) * 2004-10-21 2011-07-13 Dow AgroSciences LLC Thieno-pyrimidine compounds having fungicidal activity
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
EP2004656B1 (en) * 2006-04-07 2013-07-10 Boehringer Ingelheim International GmbH Thienopyrimidines having mnk1 /mnk2 inhibiting activity for pharmaceutical compositions
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
KR20100080597A (en) 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
KR101520086B1 (en) 2007-09-14 2015-05-14 얀센 파마슈티칼스 인코포레이티드 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones
NZ584152A (en) 2007-09-14 2011-11-25 Ortho Mcneil Janssen Pharm 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
JP5433582B2 (en) 2007-11-14 2014-03-05 ジャンセン ファーマシューティカルズ， インコーポレイテッド． Imidazo [1,2-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1012870B8 (en) 2009-05-12 2021-05-25 Addex Pharmaceuticals Sa 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors and pharmaceutical composition
PT2649069E (en) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CN104936963B (en) * 2012-11-20 2017-11-28 普罗齐纳斯有限公司 Sulfide derivative as kinases inhibitor
CA2900302C (en) * 2013-02-19 2018-07-03 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
JP6320506B2 (en) * 2013-03-12 2018-05-09 セルジーン クオンティセル リサーチ，インク． Histone demethylase inhibitor
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ME03518B (en) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
KR102502485B1 (en) 2014-01-21 2023-02-21 얀센 파마슈티카 엔.브이. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
KR101551313B1 (en) 2014-07-28 2015-09-09 충남대학교산학협력단 Novel indene derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating blindness related diseases containing the same as an active ingredient
GB201520499D0 (en) 2015-11-20 2016-01-06 Medical Res Council Technology Compounds
CN113855670B (en) * 2021-11-03 2023-06-09 上海市肺科医院 Application of A205804 in preparation of medicines for treating sepsis
CN114950492B (en) * 2022-05-31 2023-09-08 安徽大学 1, 2-diaminoanthraquinone-molybdenum disulfide composite antibacterial material for photoelectrocatalysis to kill bacteria
CN117682974B (en) * 2024-02-02 2024-04-16 济南悟通生物科技有限公司 Preparation method of 2-propionyl-1-pyrroline

Also Published As

Publication number Publication date
JP2004509059A (en) 2004-03-25
CA2390948A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
BR9916746A (en) Antiinflammatory compounds that inhibit cell adhesion
BR9910864A (en) Anti-inflammatory compounds for inhibiting cell adhesion
BR9916638A (en) Anti-Inflammatory Compounds and Cell Adhesion Inhibitor Immunosuppressants
BR0112160A (en) Glucocorticoid Selective Anti-Inflammatory Agents
BR9907788A (en) Paraglycocorticoid selective anti-inflammatory agents
BG105880A (en) Compounds useful as anti-inflammatory agents
BR9907847A (en) Selective anti-inflammatory agents for glucocorticoids
ATE267168T1 (en) BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
BR0009426A (en) Anti-inflammatory compounds and immunosuppressants that inhibit cell adhesion
UY25322A1 (en) THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS TO TREAT AND PREVENT INFLAMMATORY DISEASES AND ATEROSCLEROSIS
TR200102072T2 (en) Aromatic multi-cycle compounds as anti-inflammatory agents
BR9810385A (en) Derivatives of benzoic acid 2- (4-bromine or 4-iodine phenylamino) and their use as mek inhibitors
TR199900157T2 (en) Substituted bisindolylmaleimides for cell proliferation inhibition.
DK1144365T3 (en) Inhibitors of alpha4beta1-mediated cell adhesion
BR9809022A (en) Topical nasal anti-inflammatory compositions
BR9907655A (en) Derivatives of dihydroxyhexanoic acid
BR0111188A (en) Alpha2 beta-mediated cell adhesion inhibitors
DK0869965T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
NO982229D0 (en) Sulfur-containing di-tert-butylphenol compounds useful as anti-inflammatory agents
BRPI0411430A (en) compound, use thereof, pharmaceutical composition, pharmaceutical kit, and method of compound synthesis
NO20022000D0 (en) 6-Methoxy-2-naphthylacetic acid prodrug compositions for the treatment of inflammation
MX9605153A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
ECSP982805A (en) THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired